Ghent University Academic Bibliography

Your filters: cql: author="Van Droogenbroeck, Jan" or (type any "bookEditor issueEditor" and editor="Van Droogenbroe...

Add to list
- Journal Article
- A1
- open access
Risk factors and outcome of HHV-6 infections after allogeneic hematopoietic cell transplantation

Stefanie De Vlieger (UGent) , Juliette Van Hoorde, Ineke van Gremberghe (UGent) , Sylvia Snauwaert, Jan Van Droogenbroeck (UGent) , Tom Lodewyck, Alexander Schauwvlieghe (UGent) , Dominik Selleslag, Marijke Reynders and Jens Van Praet (UGent)

(2025) OPEN FORUM INFECTIOUS DISEASES. 12(7).
Add to list
- Journal Article
- A1
- open access
Epidemiological characteristics and outcome of viral respiratory tract infections in the first year after allogeneic hematopoietic cell transplantation

Jens Van Praet (UGent) , Andreas Huysman, Eline De Knijf, Stefanie De Buyser (UGent) , SYLVIA SNAUWAERT (UGent) , Jan Van Droogenbroeck, Tom Lodewyck, Alexander Schauwvlieghe (UGent) , Dominik Selleslag and Marijke Reynders

(2024) JOURNAL OF INFECTIOUS DISEASES. 230(4). p.944-948
Add to list
- Journal Article
- A1
- open access
Infectious diarrhea after allogeneic hematopoietic cell transplantation assessed by a multiplex polymerase chain reaction assay

Jens Van Praet (UGent) , Andreas Huysman, Eline De Knijf, Stefanie De Buyser (UGent) , Sylvia Snauwaert, Jan Van Droogenbroeck (UGent) , Tom Lodewyck, Alexander Schauwvlieghe (UGent) , Dominik Selleslag and Marijke Reynders

(2023) INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 127. p.17-22
Add to list
Trends in diagnosis, referral, red flag onset, patient profiles and natural outcome of de novo cardiac amyloidosis and their multidisciplinary implications

Philippe Debonnaire, Mathias Claeys, Maarten De Smet, Sander Trenson, Michelle Lycke, Catherine Demeester, Jan Van Droogenbroeck, An S. De Vriese, Kristof Verhoeven, Nikolaas Vantomme, et al.

(2023) ACTA CARDIOLOGICA. 77(9). p.791-804
Add to list
- Miscellaneous
Cerebellar progressive multifocal leukoencephalopathy in a patient with a history of Crohn's disease and acute myeloid leukemia

P. A. Olivier, Nicolas Salamon, Jan Casselman (UGent) , Jan Van Droogenbroeck (UGent) and L. J. Vanopdenbosch

(2020) ACTA NEUROLOGICA BELGICA. 120(3). p.759-760
Add to list
- Conference Paper
- C3
Randomized, open-label, phase 2/3 study of daratumumab (DARA) with or without JNJ-63723283, an anti-PD-1 monoclonal antibody, in relapsed/refractory multiple myeloma (RRMM)

Jan Van Droogenbroeck, Philip Vlummens, Noa Lavi, Ka Lung Wu, Jiayu Fu, Huaibao Feng, Robin L Carson, Wendy Crist, Jordan Schecter and Yael Cohen

(2018) JOURNAL OF CLINICAL ONCOLOGY. 36(15, suppl.).
Add to list
A phase I dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma

Markus Hansson, Peter Gimsing, Ashraf Badros, Titti Martinsson Niskanen, Hareth Nahi, Fritz Offner (UGent) , Morten Salomo, Elisabeth Sonesson, Morten Mau-Sorensen, Yvonne Stenberg, et al.

(2015) CLINICAL CANCER RESEARCH. 21(12). p.2730-2736
Add to list
Biclonal biphenotypical B-cell lymphocytosis: a CLL in disguise?

Barbara Depreter, Els Dumoulin (UGent) , Johan Billiet, Barbara Cauwelier, Birgit Maes, Charlotte Matthys, Jan Van Droogenbroeck, Friedel Nollet and Jan Emmerechts

(2014) BELGIAN JOURNAL OF HEMATOLOGY. 5(4). p.134-137

Academic Bibliography

Risk factors and outcome of HHV-6 infections after allogeneic hematopoietic cell transplantation

Epidemiological characteristics and outcome of viral respiratory tract infections in the first year after allogeneic hematopoietic cell transplantation

Infectious diarrhea after allogeneic hematopoietic cell transplantation assessed by a multiplex polymerase chain reaction assay

Trends in diagnosis, referral, red flag onset, patient profiles and natural outcome of de novo cardiac amyloidosis and their multidisciplinary implications

Cerebellar progressive multifocal leukoencephalopathy in a patient with a history of Crohn's disease and acute myeloid leukemia

Randomized, open-label, phase 2/3 study of daratumumab (DARA) with or without JNJ-63723283, an anti-PD-1 monoclonal antibody, in relapsed/refractory multiple myeloma (RRMM)

A phase I dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma

Biclonal biphenotypical B-cell lymphocytosis: a CLL in disguise?

Contents

Support

Contact